Filing Details
- Accession Number:
- 0001493152-20-022851
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-02 20:41:44
- Reporting Period:
- 2020-11-30
- Accepted Time:
- 2020-12-02 20:41:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1335105 | Lixte Biotechnology Holdings Inc. | LIXT | Pharmaceutical Preparations (2834) | 202903526 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1368556 | S John Kovach | 248 Route 25A, No.2 East Setauket NY 10016 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-30 | 21,100 | $4.75 | 1,540,183 | No | 4 | P | Indirect | By John S. Kovach Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By John S. Kovach Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common | Warrants to Purchase Common Stock | Acquisiton | 2020-11-30 | 21,100 | $4.75 | 21,100 | $5.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,100 | 2020-11-30 | 2025-11-30 | No | 4 | P | Indirect |
Footnotes
- The reporting person acquired 21,100 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit.